Markets › Stocks › CONCORD
CO

Concord Drugs Ltd

NSE: CONCORDBSE: 538965Healthcare
₹81.90
▼ -0.73%
NSE · 15-min delayed
Mkt Cap
₹109 Cr
P / E
77.7
P / B
2.2
ROE
2.2%
52W High
₹92.52
52W Low
₹29.00
Key Metrics
Market Cap
₹109 Cr
P / E
77.7
P / B
2.2
ROCE
5.1%
ROE
2.2%
Div Yield
-
Revenue · ₹ Cr
51
FY20
51
FY21
59
FY22
52
FY23
45
FY24
45
FY25
79
FY26
Net Profit · ₹ Cr
0
FY20
3
FY21
2
FY22
1
FY23
0
FY24
0
FY25
1
FY26
EPS · ₹ per share
₹0.4
FY20
₹3.8
FY21
₹1.8
FY22
₹1.1
FY23
₹0.5
FY24
₹0.3
FY25
₹0.9
FY26
Q1 2026 snapshot
Sales
₹38 Cr
Operating profit
-
OPM
-
Net profit
₹1 Cr
EPS
₹0.47
Scorecard · 7 axes
Quality
Weak
36/100
Valuation
Bad
77.7×
Growth
Bad
-1.2%
Profitability
Bad
3.7%
Performance
Strong
+158.0%
Entry Point
Avg
89%
Red Flags
Strong
0 flags
Shareholding Pattern
54.4%Promoter
Promoter54.4%
Public45.6%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue10.810.413.6110.2816.9937.9
Net Profit0.2270.0390.1180.1920.2170.528
NPM %2.1%0.4%0.9%1.9%1.3%1.4%
AlertPre-trade